Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia (original) (raw)

References

  1. Bergamaschi R, Romani A, Versino M, Poli R, Cosi V (1997) Clinical aspects of fatigue in multiple sclerosis. Funct Neurol 12:247-51
    CAS PubMed Google Scholar
  2. Bischoff HA, Stahelin HB, Dick W, Akos R, Knecht M, Salis C, Nebiker M, Theiler R, Pfeifer M, Begerow B, Lew RA, Conzelmann M (2003) Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res 18:343-51
    Article CAS PubMed Google Scholar
  3. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, Staehelin HB, Bazemore MG, Zee RY, Wong JB (2004) Effect of Vitamin D on falls: a meta-analysis. JAMA 291:1999-006
    Article CAS PubMed Google Scholar
  4. Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B (2005) Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 293:2257-264
    Article CAS PubMed Google Scholar
  5. Boiko A (1997) Data collection guidelines for questionnaires to be used in case-control studies of multiple sclerosis. Neurology 49:S75-0
    CAS PubMed Google Scholar
  6. Bouillon R, Okamura WH, Norman AW (1995) Structure-Function Relationships in the Vitamin D Endocrine System. Endocrine Rev 16:200-57
    CAS Google Scholar
  7. Cantorna MT, Hayes CE, DeLuca HF (1996) 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci U S A 93:7861-864
    Article CAS PubMed Google Scholar
  8. Cohen JA (1968) nominal scale agreement with provision for scaled disagreement or partial credit. Am Psychol Assoc 70:213-19
    CAS Google Scholar
  9. Cosman F, Nieves J, Komar L, Ferrer G, Herbert J, Formica C, Shen V, Lindsay R (1998) Fracture history and bone loss in patients with MS. Neurology 51:1161-165
    CAS PubMed Google Scholar
  10. Dwyer T, Blizzard L, Gies PH, Ashbolt R, Roy C (1996) Assessment of habitual sun exposure in adolescents via questionnaire-a comparison with objective measurement using polysulphone badges. Melanoma Res 6:231-39
    Article CAS PubMed Google Scholar
  11. Dwyer T, Muller HK, Blizzard L, Ashbolt R, Phillips G (1998) The use of spectrophotometry to estimate melanin density in Caucasians. Cancer Epidemiol Biomarkers Prev 7:203-06
    CAS PubMed Google Scholar
  12. Dwyer T, Prota G, Blizzard L, Ashbolt R, Vincensi MR (2000) Melanin density and melanin type predict melanocytic naevi in 19-0 year olds of northern European ancestry. Melanoma Res 10:387-94
    Article CAS PubMed Google Scholar
  13. Embry AF, Snowdon LR, Vieth R (2000) Vitamin D and seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol 48:271-72
    Article CAS PubMed Google Scholar
  14. Eyles DW, Brown J, Mackay-Sim A, McGrath J, Feron F (2002) Vitamin D3and brain development. Neuroscience. 1-4
  15. Feskanich D, Willett WC, Colditz GA (2003) Calcium, vitamin D, milk consumption, and hip fractures: a prospective study among postmenopausal women. Am J Clin Nutr 77:504-11
    CAS PubMed Google Scholar
  16. Fukazawa T, Yabe I, Kikuchi S, Sasaki H, Hamada T, Miyasaka K, et al. (1999) Association of vitamin D receptor gene polymorphism with multiple sclerosis in Japanese. J Neurol Sci 166:47-2
    Article CAS PubMed Google Scholar
  17. Goldberg P, Fleming MC, Picard EH (1986) Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D. Med Hypotheses 21:193-00
    Article CAS PubMed Google Scholar
  18. Holick MF (1994) McCollum Award Lecture, 1994: vitamin D–new horizons for the 21st century. Am J Clin Nutr 60:619-30
    CAS PubMed Google Scholar
  19. Holick MF (2004) Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 79:362-71
    CAS PubMed Google Scholar
  20. Hollis BW (2005) Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 135:317-22
    CAS PubMed Google Scholar
  21. Jablonski NG, Chaplin G (2000) The evolution of human skin coloration. J Hum Evol 39:57-06
    Article CAS PubMed Google Scholar
  22. Jorde R, Waterloo K, Saleh F, Haug E, Svartberg J (2005) Neuropsychological function in relation to serum parathyroid hormone and serum 25-hydroxyvitamin D levels The Tromso study. J Neurol
  23. Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444-452
    CAS PubMed Google Scholar
  24. Lemire JM (1992) Immunomodulatory Role of 1,25-Dihydroxyvitamin D3. Journal of Cellular Biochemistry 49:26-1
    Article CAS PubMed Google Scholar
  25. Lemire JM, Archer DC (1991) 1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J Clin Invest 87:1103-107
    Article CAS PubMed Google Scholar
  26. Magaziner J, Hawkes W, Hebel JR, Zimmerman SI, Fox KM, Dolan M, Felsenthal G, Kenzora J (2000) Recovery from hip fracture in eight areas of function. J Gerontol A Biol Sci Med Sci 55:M498-07
    CAS PubMed Google Scholar
  27. Mahon BD, Gordon SA, Cruz J, Cosman F, Cantorna MT (2003) Cytokine profile in patients with multiple sclerosis following vitamin D supplementation. J Neuroimmunol 134:128-32
    Article CAS PubMed Google Scholar
  28. Munger KL, Zhang SM, O'Reilly E, Hernan MA, Olek MJ, Willett WC, Ascherio A (2004) Vitamin D intake and incidence of multiple sclerosis. Neurology 62:60-5
    CAS PubMed Google Scholar
  29. Nieves J, Cosman F, Herbert J, Shen V, Lindsay R (1994) High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis. Neurology 44:1687-692
    CAS PubMed Google Scholar
  30. Niino M, Fukazawa T, Yabe I, Kikuchi S, Sasaki H, Tashiro K (2000) Vitamin D receptor gene polymorphism in multiple sclerosis and the association with HLA class II alleles. J Neurol Sci 177:65-1
    Article CAS PubMed Google Scholar
  31. Nowson CA, Margerison C (2002) Vitamin D intake and vitamin D status of Australians. Med J Aust 177:149-52
    PubMed Google Scholar
  32. Paty DW, Oger JJ, Kastrukoff LF, Hashimoto SA, Hooge JP, Eisen AA, Eisen KA, Purves SJ, Low MD, Brandejs V et al. (1988) MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 38:180-85
    CAS PubMed Google Scholar
  33. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227-31
    Article CAS PubMed Google Scholar
  34. Roxburgh RH, Seaman SR, Masterman T, Hensiek AE, Sawcer SJ, Vukusic S, Achiti I, Confavreux C, Coustans M, le Page E, Edan G, McDonnell GV, Hawkins S, Trojano M, Liguori M, Cocco E, Marrosu MG, Tesser F, Leone MA, Weber A, Zipp F, Miterski B, Epplen JT, Oturai A, Sorensen PS, Celius EG, Lara NT, Montalban X, Villoslada P, Silva AM, Marta M, Leite I, Dubois B, Rubio J, Butzkueven H, Kilpatrick T, Mycko MP, Selmaj KW, Rio ME, Sa M, Salemi G, Savettieri G, Hillert J, Compston DA (2005) Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology 64:1144-151
    CAS PubMed Google Scholar
  35. Salonen JT, Tuomilehto J, Nissinen A, Kaplan GA, Puska P (1989) Contribution of risk factor changes to the decline in coronary incidence during the North Karelia project: a within-community analysis. Int J Epidemiol 18:595-01
    Article CAS PubMed Google Scholar
  36. Simmons RD, Ponsonby AL, van der Mei IA, Sheridan P (2004) What affects your MS? Responses to an anonymous, Internet-based epidemiological survey. Mult Scler 10:202-11
    Article PubMed Google Scholar
  37. Sipe JC, Knobler RL, Braheny SL, Rice GP, Panitch HS, Oldstone MB (1984) A neurologic rating scale (NRS) for use in multiple sclerosis. Neurology 34:1368-372
    CAS PubMed Google Scholar
  38. Soilu-Hanninen M, Airas L, Mononen I, Heikkila A, Viljanen M, Hanninen A (2005) 25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis. Mult Scler 11:266-71
    Article CAS PubMed Google Scholar
  39. Steckley JL, Dyment DA, Sadovnick AD, Risch N, Hayes C, Ebers GC (2000) Genetic analysis of vitamin D related genes in Canadian multiple sclerosis patients. Canadian Collaborative Study Group. Neurology 54:729-32
    CAS PubMed Google Scholar
  40. Studzinski GP, Moore DC (1995) Sunlight-can it prevent as well as cause cancer? Cancer Res 55:4014-022
    CAS PubMed Google Scholar
  41. Trang HM, Cole DE, Rubin LA, Pierratos A, Siu S, Vieth R (1998) Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr 68:854-58
    CAS PubMed Google Scholar
  42. van der Mei IA, Ponsonby AL, Dwyer T, Blizzard L, Simmons R, Taylor BV, Butzkueven H, Kilpatrick T (2003) Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study. BMJ 327:316
    Article CAS PubMed Google Scholar
  43. Vieth R (1999) Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 69:842-56
    CAS PubMed Google Scholar
  44. Vieth R, Chan PC, MacFarlane GD (2001) Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr 73:288-94
    CAS PubMed Google Scholar

Download references